Jm. Zaucha et al., G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required, BIOL BLOOD, 7(11), 2001, pp. 613-619
Stable mixed donor/host hematopoietic chimerism can be uniformly establishe
d in dogs conditioned with 200 cGy TBI before dog leukocyte antigen (DLA)-i
dentical marrow transplantation and immunosuppressed with a short course of
mycophenolate mofetil (MMF) and cyclosporine (CSP) after the transplantati
on. A further decrease in the TBI dose to 100 cGy or the elimination of MMF
in this model results in graft rejection. Here we asked whether the additi
on of G-CSF-mobilized peripheral blood mononuclear cells (G-PBMC) to marrow
grafts would enhance donor engraftment in dogs conditioned with 100 cGy TB
I and given postgrafting immunosuppression with CSP alone. Using this model
, 7 of 9 dogs given only marrow cells rejected their grafts within 8 to 17
weeks after transplantation. In contrast, the addition of unmodified G-PBMC
to marrow grafts resulted in stable mixed donor/host chimerism in 5 of 8 d
ogs studied (P = .06). However, addition of the CD3-depleted fraction of G-
PBMC, which contained both CD34 cells and CD14 cells, resulted in engraftme
nt in only 1 of 7 recipients. Ve conclude that adding G-PBMC to marrow graf
ts replaced the requirement of MMF and 100 cGy of TBI, and that CD3 cells w
ere required to facilitate engraftment of marrow cells in DLA-identical rec
ipients, whereas the additional CD34 cells present in G-PBMC were not suffi
cient for this effect.